MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

CTI BioPharma Corp Company Profile (NASDAQ:CTIC)

Consensus Ratings for CTI BioPharma Corp (NASDAQ:CTIC) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.17)
Consensus Price Target: $2.20 (394.74% upside)

Analysts' Ratings History for CTI BioPharma Corp (NASDAQ:CTIC)
Show:
DateFirmActionRatingPrice TargetActions
2/10/2016Ladenburg ThalmannDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016WallachBeth CapitalDowngradeHold -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Piper JaffrayDowngradeOverweight -> Neutral$4.00 -> $0.75View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/8/2016S&P Equity ResearchLower Price Target$0.48 -> $0.39View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/14/2015Roth CapitalReiterated RatingBuy$4.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015Janney Montgomery ScottReiterated RatingBuy -> Fair Value$3.50 -> $1.94View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/10/2015HC WainwrightReiterated RatingBuy$6.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/4/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha